Form 4: ALX Oncology Holdings Inc. Director Sells Shares to Cover Tax Obligations

Sophia Randolph, Chief Medical Officer of ALX Oncology Holdings Inc., sold 3,273 shares of common stock on July 1, 2024, to satisfy tax obligations related to vesting restricted stock units.

Summary

• On July 1, 2024, Sophia Randolph, the Chief Medical Officer of ALX Oncology Holdings Inc., sold 3,273 shares of common stock.
• The shares were sold at a weighted average price of $5.8188 per share, with individual transactions ranging from $5.78 to $5.82.
• The sale was executed to cover tax obligations arising from the vesting of restricted stock units.
• Following the transaction, Randolph directly owns 327,076 shares of ALX Oncology Holdings Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and doesn't necessarily indicate a positive or negative outlook on the company.

Industry Context

Sales of shares by company insiders are a common occurrence, often related to compensation or portfolio diversification. It's important to consider the size of the sale relative to the insider's total holdings and the overall trading volume of the stock.

Stakeholder Impact

• The sale of shares by an insider could have a minor impact on shareholder sentiment, but the transaction is relatively small and likely won't significantly affect the stock price.

Key Dates